@FiercePharma: Another Bayer drug gets the eye from French regulators: Acne drug/BCP Diane-35 linked to 4 deaths, ANSM says. More | Follow @FiercePharma
@AlisonBFierce: GSK formed a joint venture in India to produce a 6-in-1 vaccine that will immunize children in developing countries. News | Follow @AlisonBFierce
> Johnson & Johnson ($JNJ) is shopping its feminine products business, The Wall Street Journal reports, as part of an effort to shed bits of the company that don't fit its growth strategies. Report
> Pfizer ($PFE) won another new use for its Prevnar 13 vaccine, broadening its market to children 6 years to 17 years old; the pneumococcal shot is now Pfizer's leading product. Report
> Merck ($MRK) won approval to market its overactive bladder patch Oxytrol over the counter. Report
> The new Actavis, created with Watson Pharmaceuticals' ($WPI) buyout of the Swiss generics maker Actavis, terminated an insulin marketing deal with biosimilars maker Bioton. Report
> The U.S. has asked for an exemption from new European rules for active pharmaceutical ingredients. Report
> Mexico's Genomma bought the Argentine painkiller brand Tafiral for $26.94 million. Report
@FierceMedDev: UNC team identifies Dx to spot worsening macular degeneration. News | Follow @FierceMedDev
@MarkHFierce: The Netherlands' Medisse nailed down a $3.5M US Series B to fund development of a bioresorbable material for implants. Release | Follow @MarkHFierce
@DamianFierce: That rumored Quintiles IPO may finally be around the corner, anon. sources tell Reuters, Bloomberg. News | Follow @DamianFierce
> Medisse raises $3.5M for new med device biomaterial. Article
> Given Imaging is no longer selling itself, but an EU investor wants a piece. More
Biotech News
@FierceBiotech: Keryx shares soar on upbeat PhIII results for CKD drug Zerenex. Article | Follow @FierceBiotech
@JohnCFierce: New bidness model: VCs launch another biotech with late-stage R&D model for Big Pharma--(think SFJ). More | Follow @JohnCFierce
@RyanMFierce: FDA called out in study of smartphone apps for melanoma. Report | Follow @RyanMFierce
> Idenix moves out of FDA limbo with J&J hep C combo pact. Story
> Takeda grabs long-awaited U.S. approval for diabetes drug Nesina. News
Biotech IT News
> FDA called out in study of smartphone apps for melanoma. Article
> Big Data analysis takes on childhood brain cancer. Story
> Hopkins mines Twitter for real flu cases in real time. More
> NIH supports Parkinson's research with online collaboration. Item
CRO News
> Is Quintiles finally going public? Article
> Covance soars on 60% income growth in Q4. Report
> GVK teams up with Endo on early-stage pain drug. Story
> Indian Supreme Court wants answers on clinical trials. More
And Finally... A flood of lawsuits challenges new U.S. rules requiring employer-provided health plans to provide contraceptives at no cost to their members. Report (sub. req.)